This inventor holds 1 USPTO granted patent. Top assignee: Bristol-Myers Company. Active years: 1976.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1976
Title: The Innovations of Anthony Partyka
Introduction
Anthony Partyka is an accomplished inventor based in Liverpool, NY (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that serve as blood platelet anti-aggregative and antihypertensive agents. His work is vital for improving health outcomes in mammals, including humans.
Latest Patents
Anthony Partyka holds a patent for "Optionally substituted 1,2,3,5-tetrahydroimidazo[2,1-b]-quinazolin-2-ones and 6-[H]-1,2,3,4-tetrahydropyrimido[2,1-b]-quinazolin-2-ones or the pharmaceutically acceptable salts thereof." This patent outlines compounds that are useful in treating various medical conditions, showcasing his innovative approach to pharmaceutical development.
Career Highlights
Throughout his career, Partyka has been associated with Bristol-Myers Company, where he has contributed to groundbreaking research and development. His expertise in medicinal chemistry has positioned him as a key player in the pharmaceutical industry.
Collaborations
Anthony Partyka has worked alongside Warren Neil Beverung, Jr., collaborating on various projects that aim to enhance the efficacy of pharmaceutical compounds. Their partnership exemplifies the importance of teamwork in driving innovation.
Conclusion
Anthony Partyka's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his role as a significant inventor. His work continues to impact the health and well-being of individuals, making him a noteworthy figure in the industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile